The Hype Surrounding Patent Foramen Ovale Closure and Cryptogenic Stroke: A Walk Through History

Area of Science:

• Cardiology
• Neurology
• Medical Devices

Background:

• Cryptogenic stroke (CS) accounts for one-third of all ischemic strokes.
• Approximately 50% of CS patients have a concomitant patent foramen ovale (PFO).
• Paradoxical embolization is a known cause of CS in patients with PFO.

Purpose of the Study:

• To review the history of patent foramen ovale (PFO) closure.
• To evaluate the efficacy of PFO device closure through clinical trials.
• To assess the role of PFO closure in managing cryptogenic stroke.

Main Methods:

• Review of historical data on PFO closure techniques.
• Analysis of clinical trial data evaluating PFO device closure efficacy.
• Synthesis of evidence supporting PFO closure for stroke reduction.

Main Results:

• Clinical trials provide data supporting the efficacy of PFO device closure.
• Evidence suggests PFO closure reduces stroke recurrence in selected CS patients.
• PFO closure is emerging as a viable treatment modality for CS.

Conclusions:

• Data favor PFO closure for reducing stroke in appropriate cryptogenic stroke patients.
• Patent foramen ovale closure should be considered a treatment option for CS.
• This review provides a foundation for understanding PFO closure's role in stroke management.